The appointments further strengthen the Company’s global R&D capabilities in mRNA therapeutics, and support the continued advancement of its proprietary mRNA platform and pipeline. At Everest, they ...
Two people infected with the same strain of COVID-19 can have vastly different experiences. One might never even sniffle, and ...
VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively ...
The market dynamics for Epstein-Barr virus (EBV) are evolving, driven by the high prevalence of infection worldwide, the growing recognition of EBV-associated malignancies and other complications, and ...
Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammation. Meanwhile, ...
Communication with FDA at recent Type B meeting provided clear guidance for next steps to prepare IND application to support ...
Sacramento-area resident Lisa Ferrero, was only given 5 years to live before she participated in a clinical trial exploring ...
Novartis bought an mRNA-coded autoimmune T-cell engager candidate for up to $7.8 billion, as Shionogi offered $2 billion to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results